• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出租车几何量化系统评估计算机模拟方法的性能:以腺苷受体配体为例的研究

A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.

机构信息

Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688, Kraków, Poland.

Department of Pharmaceutical Chemistry, Phillips-University, Marbacher Weg 6, 35037, Marburg, Germany.

出版信息

J Comput Aided Mol Des. 2020 Jun;34(6):697-707. doi: 10.1007/s10822-020-00301-5. Epub 2020 Feb 28.

DOI:10.1007/s10822-020-00301-5
PMID:32112287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190583/
Abstract

Among still comparatively few G protein-coupled receptors, the adenosine A receptor has been co-crystallized with several ligands, agonists as well as antagonists. It can thus serve as a template with a well-described orthosteric ligand binding region for adenosine receptors. As not all subtypes have been crystallized yet, and in order to investigate the usability of homology models in this context, multiple adenosine A receptor (AAR) homology models had been previously obtained and a library of lead-like compounds had been docked. As a result, a number of potent and one selective ligand toward the intended target have been identified. However, in in vitro experimental verification studies, many ligands also bound to the AAR and the AAR subtypes. In this work we asked the question whether a classification of the ligands according to their selectivity was possible based on docking scores. Therefore, we built an AAR homology model and docked all previously found ligands to all three receptor subtypes. As a metric, we employed an in vitro/in silico selectivity ranking system based on taxicab geometry and obtained a classification model with reasonable separation. In the next step, the method was validated with an external library of, selective ligands with similarly good performance. This classification system might also be useful in further screens.

摘要

在数量相对较少的 G 蛋白偶联受体中,已对几种配体(激动剂和拮抗剂)与腺苷 A 受体进行了共结晶。因此,它可以作为一个模板,具有描述良好的腺苷受体的正位配体结合区域。由于尚未对所有亚型进行结晶,并且为了研究同源模型在这种情况下的可用性,之前已经获得了多种腺苷 A 受体 (AAR) 同源模型,并对接了一系列类先导化合物。结果,确定了一些针对预期靶标的有效且选择性的配体。然而,在体外实验验证研究中,许多配体也与 AAR 和 AAR 亚型结合。在这项工作中,我们提出了一个问题,即根据对接评分是否可以对配体进行分类。因此,我们构建了一个 AAR 同源模型,并将之前发现的所有配体对接至所有三种受体亚型。作为一种度量标准,我们采用了基于出租车几何形状的体外/计算选择排名系统,并获得了具有合理分离度的分类模型。在下一步中,该方法通过具有类似良好性能的外部选择性配体库进行了验证。该分类系统在进一步的筛选中也可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/c53ace4789c3/10822_2020_301_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/bb782b585a5b/10822_2020_301_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/e706fd1ed5dd/10822_2020_301_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/7de602c31e18/10822_2020_301_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/c53ace4789c3/10822_2020_301_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/bb782b585a5b/10822_2020_301_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/e706fd1ed5dd/10822_2020_301_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/7de602c31e18/10822_2020_301_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8a9/7190583/c53ace4789c3/10822_2020_301_Fig4_HTML.jpg

相似文献

1
A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.出租车几何量化系统评估计算机模拟方法的性能:以腺苷受体配体为例的研究
J Comput Aided Mol Des. 2020 Jun;34(6):697-707. doi: 10.1007/s10822-020-00301-5. Epub 2020 Feb 28.
2
Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.基于片段从同源模型中发现亚型选择性腺苷受体配体
J Med Chem. 2015 Dec 24;58(24):9578-90. doi: 10.1021/acs.jmedchem.5b01120. Epub 2015 Dec 8.
3
Structure of the Adenosine A Receptor Reveals the Basis for Subtype Selectivity.腺苷 A 受体结构揭示了亚型选择性的基础。
Cell. 2017 Feb 23;168(5):867-877.e13. doi: 10.1016/j.cell.2017.01.042.
4
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.吡唑并[1',5':1,6]嘧啶并[4,5-d]哒嗪-4(3H)-酮类作为选择性人 A(1) 腺苷受体配体。
Bioorg Med Chem. 2010 Nov 15;18(22):7890-9. doi: 10.1016/j.bmc.2010.09.043. Epub 2010 Sep 22.
5
New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations.使用有监督分子动力学模拟深入了解腺苷 A1 受体拮抗剂选择性的关键决定因素。
Biomolecules. 2020 May 7;10(5):732. doi: 10.3390/biom10050732.
6
Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of ARs.腺苷受体配体:香豆素-查尔酮杂合体作为 ARs 活性调节剂。
Molecules. 2020 Sep 19;25(18):4306. doi: 10.3390/molecules25184306.
7
Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.A1和A2A腺苷受体的分子模拟:通过对接研究比较基于视紫红质和β2肾上腺素能的同源模型
J Comput Chem. 2009 Jan 15;30(1):14-32. doi: 10.1002/jcc.21001.
8
A3 adenosine receptor: homology modeling and 3D-QSAR studies.A3 腺苷受体:同源建模和 3D-QSAR 研究。
J Mol Graph Model. 2013 May;42:60-72. doi: 10.1016/j.jmgm.2013.03.001. Epub 2013 Mar 19.
9
Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.腺苷A1受体的细胞外环2在正构配体亲和力和激动剂效力中起关键作用。
Mol Pharmacol. 2016 Dec;90(6):703-714. doi: 10.1124/mol.116.105007. Epub 2016 Sep 28.
10
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A Antagonists.优化 2-氨基-4,6-二芳基嘧啶-5-甲腈作为强效和选择性的 A 拮抗剂。
J Med Chem. 2022 Feb 10;65(3):2091-2106. doi: 10.1021/acs.jmedchem.1c01636. Epub 2022 Jan 22.

本文引用的文献

1
Understanding Ligand Binding Selectivity in a Prototypical GPCR Family.理解典型 G 蛋白偶联受体家族中的配体结合选择性。
J Chem Inf Model. 2019 Jun 24;59(6):2830-2836. doi: 10.1021/acs.jcim.9b00298. Epub 2019 Jun 4.
2
The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.基于药效团的 3D-QSAR 建模与虚拟筛选在安全性分析中的整合:以鉴定对腺苷受体 A2A 具有拮抗活性的 1897 种已知药物为例的研究
PLoS One. 2019 Jan 3;14(1):e0204378. doi: 10.1371/journal.pone.0204378. eCollection 2019.
3
Structure of the adenosine-bound human adenosine A receptor-G complex.
人源腺苷受体-G 复合物结合腺苷的结构。
Nature. 2018 Jun;558(7711):559-563. doi: 10.1038/s41586-018-0236-6. Epub 2018 Jun 20.
4
Structures of Human A and A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.人 A 和 A 腺苷受体与黄嘌呤结构揭示了选择性的决定因素。
Structure. 2017 Aug 1;25(8):1275-1285.e4. doi: 10.1016/j.str.2017.06.012. Epub 2017 Jul 14.
5
Discovery of Novel and Selective Adenosine A Receptor Antagonists for Treating Parkinson's Disease through Comparative Structure-Based Virtual Screening.通过比较结构基于虚拟筛选发现新型和选择性腺苷 A 受体拮抗剂用于治疗帕金森病。
J Chem Inf Model. 2017 Jun 26;57(6):1474-1487. doi: 10.1021/acs.jcim.7b00188. Epub 2017 May 15.
6
Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.大脑中的腺苷A1和A2A受体:当前研究及其在神经退行性变中的作用
Molecules. 2017 Apr 23;22(4):676. doi: 10.3390/molecules22040676.
7
Structure of the Adenosine A Receptor Reveals the Basis for Subtype Selectivity.腺苷 A 受体结构揭示了亚型选择性的基础。
Cell. 2017 Feb 23;168(5):867-877.e13. doi: 10.1016/j.cell.2017.01.042.
8
Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists.基于结构的未探索化学空间中新型腺苷受体激动剂的筛选。
ACS Chem Biol. 2016 Oct 21;11(10):2763-2772. doi: 10.1021/acschembio.6b00357. Epub 2016 Aug 22.
9
GPCRdb: the G protein-coupled receptor database - an introduction.GPCRdb:G蛋白偶联受体数据库——简介
Br J Pharmacol. 2016 Jul;173(14):2195-207. doi: 10.1111/bph.13509. Epub 2016 Jun 3.
10
Medicinal chemistry of adenosine, P2Y and P2X receptors.腺苷、P2Y 和 P2X 受体的药物化学
Neuropharmacology. 2016 May;104:31-49. doi: 10.1016/j.neuropharm.2015.12.001. Epub 2015 Dec 12.